LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$4.52
-4.24%
Mkt Cap $141.72M
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (7 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+54.9%
Consensus $7.00 vs current $4.52
NASDAQ·Healthcare·Biotechnology
$4.52
-4.24%
Mkt Cap $141.72M
Buy
6
Hold
2
Sell
0
Price Target (7 analysts)
$7.00
Range $7.00 – $7.00
+54.9%
Consensus $7.00 vs current $4.52